As of 2025-07-01, the Intrinsic Value of Dyne Therapeutics Inc (DYN) is -16.15 USD. This DYN valuation is based on the model Peter Lynch Fair Value. With the current market price of 9.52 USD, the upside of Dyne Therapeutics Inc is -269.63%.
Based on its market price of 9.52 USD and our intrinsic valuation, Dyne Therapeutics Inc (DYN) is overvalued by 269.63%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -16.15 - -16.15 | -16.15 | -269.63% |
| P/E | (42.31) - (81.71) | (63.55) | -767.5% |
| DDM - Stable | (23.50) - (81.87) | (52.68) | -653.4% |
| DDM - Multi | (2.48) - (6.91) | (3.67) | -138.6% |
| Market Cap (mil) | 1,082.14 |
| Beta | 2.10 |
| Outstanding shares (mil) | 113.67 |
| Enterprise Value (mil) | 609.88 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.59% |
| Cost of Debt | 5.00% |
| WACC | 7.13% |